Últimas noticias sobre Entero Therapeutics (NASDAQ:ENTO) Bolsa

Entero Therapeutics

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Movers_Stocks

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADPT

CXAI

ENTO

HRTG

IIIN

LION

LSAK

MLNK

MULN

OLMA

RNAC

SGMO

SHCO

SLSR

Sangamo Therapeutics se dispara tras anunciar un acuerdo exclusivo con Eli Lilly sobre tecnología genética patentada. ¿Qué implica esto?

Acciones de Sangamo Therapeutics (SGMO) se disparan un 40%; Aquí están 20 acciones que se mueven en premercado

Entero Therapeutics Inc

Entra ASA

Entourage Health Corp

B. Riley Securities analyst Dave Kang maintains Ribbon Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) with a Buy and lowers the price target from $7.5 to $6.

Price Target

Analyst Ratings

RBBN

B. Riley Securities Maintains Buy on Ribbon Communications, Lowers Price Target to $6

ODDITY Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) shares are moving higher Wednesday after the company reported better-than-expected first-quarter earnings Tuesday <a href="https://www.benzinga.com//node/45082744">after the market close</a>.
What To Know: The consumer tech platform company reported first-quarter adjusted earnings per share of 69 cents, beating analyst estimates of 62 cents. In addition, Oddity reported first-quarter sales of $268.08 million, beating analyst estimates of $260.69 million and representing a 27% year-over-year increase.
Outlook: The company raised its guidance its for the 2025 fiscal year. Oddity now anticipates adjusted earnings per share of $1.99 to $2.04, versus analyst estimates of $1.93. The company previously guided for adjusted earnings per share of $1.94 to $1.98, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Oddity also raised its sales guidance from between $776 million to $785 million to a new range between $790 million and $798 million, versus analyst estimates of $784.1 million.
For the second quarter, the company sees adjusted earnings per share of 85 cents to 89 cents, versus analyst estimates of 84 cents. Oddity sees second-quarter sales of $235 million to $239 million, versus analyst estimates of $232.54 million.
&#8220;Our early and aggressive investments in this transformation allow us to sustain a powerful financial model, to beat our guidance, and to once again raise our full year outlook as we have done in the past 8 quarters since our IPO,&#8221; said Oran Holtzman, Oddity co-founder and CEO.
Related Link: <a href="https://www.benzinga.com/insights/news/25/04/45107632/1000-invested-in-brown-brown-5-years-ago-would-be-worth-this-much-today">$1000 Invested In Brown &amp; Brown 5 Years Ago Would Be Worth This Much Today</a>
ODD Price Action: At the time of writing, Oddity shares were up 26.3% at $59.96, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
This illustration was generated using artificial intelligence via Midjourney.

What's Going On With Oddity Tech Stock Wednesday?

On Jan. 20, 2025, Donald Trump was sworn in as the 47th president of the U.S., an event watched by <a href="https://www.benzinga.com/general/entertainment/25/01/43139381/how-many-people-watched-donald-trumps-2025-inauguration-spoiler-less-than-biden-four-years-ago">millions of people </a>on television and highly anticipated by investors.
Here's a look back at the event and how investments in several well-known ETFs and Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) have performed during Trump's first 100 days in office.
Trump Inauguration: Trump has <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/45069781/trumps-first-100-days-what-he-delivered-where-he-fell-short-how-markets-reacted">passed the 100 day mark</a> in the White House for his second presidency, leading to report cards and grades on all the campaign promises he made and an early look at how the economy is looking.
During his inauguration, <a href="https://www.benzinga.com/government/regulations/25/01/43085323/trump-sworn-in-as-47th-president-declares-golden-age-of-america-begins-right-now">Trump promised </a>to make Americans wealthy with various items like tariffs, tax cuts and government cost savings.
"The golden age of America begins right now," Trump said. "From this day forward, our country will flourish and be respected again all over the world."
Fast forward 100 days and the stock market has fallen with many major indexes negative. Here's a look at how investments made when Trump took over the presidency would have performed.
Read Also:<a href="https://www.benzinga.com/news/global/25/04/45047432/trump-says-i-run-the-country-and-the-world-yet-polls-plummet"> Trump Says &#8216;I Run The Country And The World,&#8217; Yet Polls Plummet</a>
Investing $1,000 in SPY, QQQ, BTC: Trump's inauguration took place on a Sunday with the stock market closed. Investors who believed a Trump presidency would make the stock market go up could have bought stocks or ETFs at close on that Friday (Jan. 17, 2025) ahead of the inauguration.
Here is a look at how much $1,000 investments in the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) and Bitcoin would be worth after 100 days, using closing prices for the ETFs from April 29.
For the price of Bitcoin in this illustration, the opening price on Jan. 20 was used, with the price at 4 p.m. ET on April 29 used.
$1000 Investments:
<ul>
<li>SPY: 1.67 shares, now worth $925.71, down 7.4%</li>
<li>QQQ: 1.92 shares, now worth $913.02, down 8.7%</li>
<li>Bitcoin: 0.00989 BTC, now worth $935.76, down 6.4%</li>
<li>Total: Now worth $2,774.49, down 7.5%</li>
</ul>
As you can see, investments in the major ETFs and Bitcoin have fallen during Trump's first 100 days. In fact the returns of the S&amp;P 500, which is tracked by SPY, have been historically bad when compared to other presidents.
How Trump Stacks Up: The 7.4% drop during Trump's first 100 days is the worst start to a four-year term since Richard Nixon in 1973, as reported by CNBC, citing data from CFRA Research.
In 1973, the S&amp;P 500 fell 9.9% in the first 100 days under Nixon. For comparison, the S&amp;P 500 has an average return of 2.1% in the first 100 days of a presidency, dating back to 1944.
Also keep in mind that recent presidents had some of the best stock market performances in their first 100 days in office. Here's the recent returns and their rating since 1944:
<ul>
<li>2009: Barack Obama, +8.4%, fourth best</li>
<li>2013: Barack Obama, +7.5%, sixth best</li>
<li>2017: Donald Trump, +5.0%, seventh best</li>
<li>2021: Joe Biden, +8.5%, third best</li>
<li>2025: Donald Trump, -7.4%, 20th (of 21 in the ranking), second worst</li>
</ul>
Markets traded higher in November and December on the heels of Trump's win with some of the largest companies in the world hitting new all-time highs. January and February also saw gains after Trump took office.
Attention shifted towards economic policies and foreign in March and April with markets diving in April after Trump's tariff announcement.
For Trump&#8217;s <a href="https://www.benzinga.com/markets/futures/18/01/11066769/the-stock-markets-rally-under-trump-among-the-best-ever-heres-how-his">first year in office in 2017,</a> the S&amp;P 500 Index finished the year up 21.7% for one of the best performances during a president's first year in office. &nbsp;
Earlier this year, <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this">Benzinga readers predicted </a>where the SPY will finish 2025 during Trump's first year back in office.
&#8220;What do you think the return will be in 2025, his first year back,&#8221; Benzinga asked.
The results were:
<ul>
<li>16%+: 26%</li>
<li>11% to 15%: 22%</li>
<li>Will Decline: 22%</li>
<li>6% to 10%: 19%</li>
<li>0% to 5%:&nbsp;12%</li>
</ul>
The poll found the largest percentage believes the S&amp;P 500 Index will post gains of at least 16% in 2025. The 11% to 15% range came in second place at 22%.
It&#8217;s also worth pointing out that the S&amp;P 500 decline in 2025 was actually tied for second in the poll at 22%, which could mean 2025 is a make-or-break year.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent043025">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent043025"><img loading="lazy" decoding="async" width="1024" height="330" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30094118/Picture1-6-1024x330.png" alt="" class="wp-image-895027" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30094118/Picture1-6-1024x330.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30094118/Picture1-6-300x97.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30094118/Picture1-6-768x248.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30094118/Picture1-6.png 1430w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Photo: Evan El-Amin via Shutterstock

Entertainment

Education

Politics

$BTC

Trump 100 Days: If You Invested $1,000 In SPY, QQQ, Bitcoin When Trump Was Inaugurated, Here's How Much You'd Have Today

B. Riley Securities analyst Naved Khan maintains Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with a Buy and raises the price target from $6000 to $6100.

BKNG

B. Riley Securities Maintains Buy on Booking Holdings, Raises Price Target to $6100

JP Morgan analyst Samik Chatterjee maintains Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Neutral and lowers the price target from $39 to $36.

SMCI

JP Morgan Maintains Neutral on Super Micro Computer, Lowers Price Target to $36

WIIM

TSLA

Tesla shares are trading lower amid overall market weakness on macroeconomic concerns. Investors may also be assessing the company's recent earnings report and reports of House Republicans proposing an EV fee to fund transportation programs.

JP Morgan analyst Doug Anmuth maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Overweight and raises the price target from $640 to $670.

SPOT

JP Morgan Maintains Overweight on Spotify Technology, Raises Price Target to $670

JP Morgan analyst John Ivankoe maintains Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Overweight and lowers the price target from $105 to $100.

SBUX

JP Morgan Maintains Overweight on Starbucks, Lowers Price Target to $100

If you're feeling uneasy about the economy lately, you're definitely not alone. A recent <a href="https://www.numerator.com/resources/blog/consumer-reaction-tariffs-us/">survey</a> from Numerator found that 72% of Americans are worried about a recession hitting within the next year. Rising tariffs, stock market swings, and price hikes are making a lot of people rethink their financial plans.
<a href="https://www.benzinga.com/personal-finance/25/04/44956464/be-a-super-smart-stock-investor-suze-orman-on-why-you-shouldnt-fear-a-market-dip">Suze Orman</a>, personal finance expert and bestselling author, says it's smart to be concerned — but even smarter to take action. In a <a href="https://www.suzeorman.com/blog/Dont-Just-Worry-About-a-Recession-Prepare">blog post</a> last week, she lays out some practical steps you can take now to get your finances ready, just in case things get rough.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Cut Back on Spending</h2>
First up: tighten your budget. Orman says now isn't the time for big vacations, splurges, or retail therapy. "Every dollar you don't spend today is a dollar that can be used for so many smart recession-protection moves," she wrote.
This advice lines up with what's already happening across the country. Numerator reports that 83% of shoppers are planning to change their spending habits because of <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44962716/americans-rush-to-buy-cars-ahead-of-tariff-price-hikes-fed-beige-book-shows">tariff-related price hikes</a> — and nearly half are hunting for more sales and coupons.
<h2 class="wp-block-heading">Boost Your Emergency Fund</h2>
Orman's next piece of advice is to beef up your emergency savings. She recommends having at least a year's worth of living expenses saved up. That way, if you lose your job, see reduced hours, or have any income disruption, you'll have a financial safety net to fall back on.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
If you&#8217;re expecting a <a href="https://www.benzinga.com/25/04/44590930/the-average-tax-refund-is-3000-suze-orman-says-this-is-how-to-spend-it-wisely">tax refund</a> soon, Orman suggests moving it straight into your emergency fund. It&#8217;s an easy way to give your savings a quick boost without dipping into your regular income.
<h2 class="wp-block-heading">Have Honest Conversations With Your Adult Kids</h2>
Many parents help out their adult children, but Orman says now's the time to set some boundaries. If you're covering a specific need, like rent, that&#8217;s one thing. But giving money for extras? That can hurt your own financial stability — especially if a recession hits.
Orman says, "I have a problem with that, no matter what the economic outlook, but it is insane to do this if you are not fully prepared for a recession." Having a candid conversation now could save you a lot of stress later.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Know Your Health Insurance Options</h2>
If you lose your job, keeping your <a href="https://www.benzinga.com/news/25/04/44885628/mark-cuban-says-health-insurance-shouldnt-exist-you-dont-have-to-grab-every-nickel-when-its-the-health-of-the-entire-country-at-stake">health insurance</a> through COBRA — a federal regulation allowing employees to continue their coverage for a limited time — can be expensive. Sometimes, policyholders end up paying 102% of the full premium. Orman recommends looking into Affordable Care Act plans as a backup option. Depending on your income, you might qualify for a much lower premium.
A little research now could save you thousands if you need coverage later.
<h2 class="wp-block-heading">Upgrade Your Skills</h2>
Finally, Orman says this is a great time to build new job skills. Whether it's taking a course, learning new software, or updating certifications, adding to your resume now could help you keep your current job — or land a new one faster if layoffs happen.
According to Numerator, more Americans are worried about job security now than just a few months ago. Having up-to-date skills could make all the difference.
Taking a few smart steps today could help you weather whatever the economy brings tomorrow — and following Orman's advice might make you feel a whole lot more prepared.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
</ul>
Image: Shutterstock

Personal Finance

More Than 70% Of Americans Concerned About A Recession This Year: Here's How Suze Orman Says To Prepare

Scilex Holding Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has received notification from The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company was required to maintain a minimum closing bid price of $1.00 per share for at least ten consecutive trading days. This requirement was met on April 30, 2025.
The Company's common stock and public warrants will continue to trade on the Nasdaq Capital Market under the symbols "SCLX" and "SCLXW", respectively.

SCLX

Scilex Holding Company Regains NASDAQ Compliance With Minimum Bid Price Requirement

Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) has seen a massive spike in burn activity and on-chain growth, fueling speculation of a <a href="https://www.benzinga.com/money/shiba-inu-price-prediction#:~:text=Average%20Prediction%3A%20%240.00010-,Maximum%20Prediction%3A%20%240.00010,on%20investment%20from%20current%20valuations.">macro trend reversal</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001317</td>
<td>$7.8 billion</td>
<td>-3.3%</td>
<td>-3%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1703</td>
<td>$25.4 billion</td>
<td>-4.5%</td>
<td>-4.9%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.058756</td>
<td>$3.7 billion</td>
<td>-3%</td>
<td>-1.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: TradingView analyst Wavervanir International <a href="https://www.tradingview.com/chart/SHIBUSD/zjvvwYOe-SHIBUSD-Watching-this/">highlighted</a> a potential macro bullish reversal forming at the $0.00001114 support zone. 
The recent bounce follows an extended drawdown, suggesting buyers are stepping in at structurally important levels.
Key resistance targets are outlined at $0.00002393, $0.00003209 and $0.00004523.
The analyst assigns a 65% probability of a bullish breakout, with a 25% chance of breakdown and 10% likelihood of sideways chop. 
Historical consolidation zones from mid-2023 to early 2024 further support the idea of accumulation in the current range.
Statistics: Data from Shibburn shows that over 16.2 million SHIB were burned in the past 24 hours, with 15.4 million eliminated in just one transaction. 
The burn rate soared by 2,093.8%, reflecting a sudden increase in deflationary pressure on the meme coin.
On the fundamentals side, Shibarium, Shiba Inu's Layer-2 blockchain, surpassed 200 million total addresses, with new account registrations jumping from 395 to 859 in just 24 hours. 
Although daily transactions dipped over the past four days, the broader trend has been upward since mid-April.
IntoTheBlock data shows Shiba Inu large transaction volume narrowed by 24.9% while transactions greater than $100,000 declined from 99 to 80.
Community News: Shibarium continues to gain traction in community tools, Zypto App <a href="https://x.com/ZyptoApp/status/1917260194863587558">announced</a>, in a X post on April 29, it will become the first DeFi wallet to natively integrate both ShibaSwap and Shibarium.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45069965/shiba-inu-down-2-can-shibariums-explosive-growth-fuel-a-shib-rally">Shiba Inu Down 2%: Can Shibarium&#8217;s Explosive Growth Fuel A SHIB Rally?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Shiba Inu Burn Rate Skyrockets 2,094%: What Is Going On?

Truist Securities analyst Youssef Squali maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Hold and lowers the price target from $14 to $11.

SNAP

Truist Securities Maintains Hold on Snap, Lowers Price Target to $11

Jones Trading analyst Catherine Novack downgrades Regulus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLS#NASDAQ">RGLS</a>) from Buy to Hold and lowers the price target from $8 to $7.

Downgrades

RGLS

Jones Trading Downgrades Regulus Therapeutics to Hold, Lowers Price Target to $7

Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) reported upbeat fourth-quarter financial results and issued FY26 revenue <a href="https://www.benzinga.com/quote/cvlt/earnings">guidance above estimates</a>.
CommVault Systems reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of 93 cents per share. The company reported quarterly sales of $275.04 million which beat the analyst consensus estimate of $262.43 million.
&#8220;It was a record-breaking year at Commvault,&#8221; said Sanjay Mirchandani, President and CEO. &#8220;Commvault surpassed all key metrics, ended the year with over 12,000 subscription customers, and is firmly positioned as a growth company with subscription revenue up 45% in Q4. We continue to deliver cloud-first innovations that solve a hard problem for customers – strengthening their cyber resilience.&#8221;
CommVault said it sees FY2026 sales of $1.130 billion to $1.140 billion, versus estimates of $1.10 billion.
Commvault shares fell 1.3% to trade at $166.52 on Wednesday.
These analysts made changes to their price targets on Commvault following earnings announcement.
<ul>
<li>RBC Capital analyst Brad Erickson maintained CommVault Systems with a Sector Perform and raised the price target from $175 to $185.</li>
<li>Wells Fargo analyst Aaron Rakers maintained the stock with an Overweight rating and raised the price target from $180 to $190..</li>
<li>Oppenheimer analyst Param Singh maintained CommVault Systems with an Outperform rating and raised the price target from $180 to $200.</li>
</ul>
Considering buying CVLT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="621" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30134502/image-239-1024x621.png" alt="" class="wp-image-895524" style="width:572px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30134502/image-239-1024x621.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30134502/image-239-300x182.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30134502/image-239-768x466.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30134502/image-239.png 1098w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

CVLT

These Analysts Boost Their Forecasts On Commvault Systems Following Q4 Results

<a href="https://www.bloomberg.com/news/articles/2025-04-30/rivian-stockpiled-ev-batteries-from-asia-ahead-of-trump-tariffs">https://www.bloomberg.com/news/articles/2025-04-30/rivian-stockpiled-ev-batteries-from-asia-ahead-of-trump-tariffs</a>

General

RIVN

'Rivian Stockpiled EV Batteries From Asia Ahead of Trump Tariffs'- Bloomberg

Truist Securities analyst Srikripa Devarakonda maintains Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) with a Buy and lowers the price target from $975 to $940.

REGN

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $940

Canaccord Genuity analyst Whitney Ijem downgrades Regulus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLS#NASDAQ">RGLS</a>) from Buy to Hold and lowers the price target from $28 to $11.

Canaccord Genuity Downgrades Regulus Therapeutics to Hold, Lowers Price Target to $11

Delta Air Lines Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) shares traded as low as $39.94 on Wednesday as investors reacted to weaker-than-expected results from Norwegian Cruise Line Holdings that reignited concerns about discretionary travel demand amid mounting <a href="https://www.benzinga.com/news/econ-s/25/04/45108426/as-growth-falters-sentiment-slips-economist-says-risks-to-the-economic-outlook-are-increasing">economic headwinds</a>.
What To Know: Norwegian missed EPS and revenue estimates for the first quarter, posting a 56% year-over-year decline in EPS and <a href="https://www.benzinga.com/news/earnings/25/04/45106948/norwegian-cruise-line-tumbles-after-earnings-miss-still-confident-in-2025-guidance">slightly weaker sales</a>. Despite reaffirming its full-year guidance, the cruise operator reported softening booking trends and a modest downward revision in forward net yield growth.
Notably, management cited macroeconomic volatility, foreign exchange losses and changing consumer behavior — such as lower air-inclusive package participation — as key pressures.
Read Also: <a href="https://www.benzinga.com/news/25/04/45103964/pinterest-pins-stock-falls-after-snap-earnings-spark-digital-ad-concerns">Pinterest Stock Falls After Snap Earnings Spark Digital Ad Concerns</a>
While Delta is not in the cruise sector, its core business of premium air travel closely correlates with consumer discretionary spending on leisure and vacation-related travel.
Norwegian's commentary on reduced passenger air participation and a weaker 12-month forward booking position raised red flags about the resilience of U.S. outbound travel demand, particularly for higher-cost international routes.
Coupled with broader concerns about an economic slowdown following this morning's <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/45100047/recession-odds-spike-wall-street-tumbles-as-q1-gdp-surprisingly-contracts-be-patient-trump-responds">negative GDP surprise</a>, Delta and other travel-exposed stocks faced renewed selling pressure.
Read Also: <a href="https://www.benzinga.com/25/04/45104438/starbucks-stock-tumbles-on-q2-earnings-ceo-says-progress-is-happening-below-the-surface">Starbucks Stock Tumbles On Q2 Earnings, CEO Says Progress Is Happening &#8216;Below The Surface&#8217;</a>
<h2 class="wp-block-heading">How To Buy DAL Stock</h2>
By now you're likely curious about how to participate in the market for Delta Air Lines &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Delta Air Lines, which is trading at $41.4 as of publishing time, $100 would buy you 2.42 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, DAL has a 52-week high of $69.98 and a 52-week low of $34.74. Delta Air Lines stock was down 1.34% at $41.52 at the time of publication Wednesday.
Photo: <a href="https://www.shutterstock.com/g/kamilpetran">kamilpetran</a>/Shutterstock.

Delta Air Lines Shares Fall As Travel Demand Outlook Weakens: What's Going On?

Truist Securities analyst Tobey Sommer maintains Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) with a Hold and lowers the price target from $82 to $70.

Truist Securities Maintains Hold on Insperity, Lowers Price Target to $70

Truist Securities analyst Patrick Scholes maintains Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) with a Hold and lowers the price target from $251 to $223.

Truist Securities Maintains Hold on Hilton Worldwide Holdings, Lowers Price Target to $223

Biotech

Press Releases

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum

Legal

Kuehn Law Encourages ENTO, PULM, PIK, and PFC Investors to Contact Law Firm

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO

Comments

Entero Therapeutics

Noticias

Últimas noticias sobre Entero Therapeutics (NASDAQ:ENTO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL